This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brander, M A Articles by Jousimies-Somer, H R Search for Related Content PubMed PubMed Citation Articles by Brander, M A Articles by Jousimies-Somer, H R

Evaluation of the RapID ANA II and API ZYM systems for identification of Actinomyces species from clinical specimens.

Department in Lappeenranta, National Public Health Institute, Lappeenranta, Finland.

ABSTRACT

Classification and identification of fermentative actinomycetes are labor-intensive and problematic. In this study, we evaluated the applicability and reliability of the RapID ANA II system (Innovative Diagnostic Systems, Inc., Atlanta, Ga.) and the discriminatory value of the API ZYM system (Societes Analytab Products Inc., La Balme Les Grottes, France) in the identification of Actinomyces-like bacteria by using conventional methods as a reference. Eighty-five strains, including 71 isolates from mixed anaerobic infections and 14 reference strains, were tested. The RapID ANA II system correctly identified all Actinomyces odontolyticus strains and 65% of Actinomyces israelii strains. All Arcanobacterium haemolyticum strains were misidentified as Actinomyces pyogenes. The most common isolates in the study were Actinomyces meyeri-like organisms, 84% of which, however, were aerotolerant. The identification of these aerotolerant strains thus remains unresolved and warrants further studies. New characteristics and changes to the conventional API ZYM enzyme profiles are suggested. The API ZYM enzyme profiles of A. odontolyticus and A. israelii were very similar, the only discriminating enzyme being alpha-fucosidase. In differentiation between A. pyogenes and Arcanobacterium haemolyticum, the production of beta-glucuronidase by the former and the production of acid phosphatase by the latter are suggested as new helpful characteristics for use in clinical laboratories. In summary, the RapID ANA II and API ZYM systems can be used as rapid preliminary methods in the identification of Actinomyces species but accurate identification requires supplementary conventional tests and gas-liquid chromatography.

This article has been cited by other articles:

• Santala, A.-M., Sarkonen, N., Hall, V., Carlson, P., Jousimies-Somer, H., Kononen, E. (2004). Evaluation of Four Commercial Test Systems for Identification of Actinomyces and Some Closely Related Species. J. Clin. Microbiol. 42: 418-420 [Abstract] [Full Text]  
• Clarridge, J. E. III, Zhang, Q. (2002). Genotypic Diversity of Clinical Actinomyces Species: Phenotype, Source, and Disease Correlation among Genospecies. J. Clin. Microbiol. 40: 3442-3448 [Abstract] [Full Text]  
• Sarkonen, N., Kononen, E., Summanen, P., Kononen, M., Jousimies-Somer, H. (2001). Phenotypic Identification of Actinomyces and Related Species Isolated from Human Sources. J. Clin. Microbiol. 39: 3955-3961 [Abstract] [Full Text]  
• Hall, V., Talbot, P. R., Stubbs, S. L., Duerden, B. I. (2001). Identification of Clinical Isolates of Actinomyces Species by Amplified 16S Ribosomal DNA Restriction Analysis. J. Clin. Microbiol. 39: 3555-3562 [Abstract] [Full Text]  
• Wüst, J., Steiger, U., Vuong, H., Zbinden, R. (2000). Infection of a Hip Prosthesis by Actinomyces naeslundii. J. Clin. Microbiol. 38: 929-930 [Abstract] [Full Text]  
• Sabbe, L. J. M., Van De Merwe, D., Schouls, L., Bergmans, A., Vaneechoutte, M., Vandamme, P. (1999). Clinical Spectrum of Infections Due to the Newly Described Actinomyces Species A. turicensis, A. radingae, and A. europaeus. J. Clin. Microbiol. 37: 8-13 [Abstract] [Full Text]